Medical Devices

Mon, 11/12/2017 - 10:00
Coventry, UK, 11th December 2017 / Sciad Newswire / Medherant, a leader in next-generation transdermal drug delivery, ha
Fri, 17/11/2017 - 15:25
Coventry, UK, 17th November 2017 / Sciad Newswire / Medherant is delighted to announce they have been awarded the ‘Excel
Mon, 26/06/2017 - 07:30
Coventry, UK, 26th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a nex
Mon, 12/06/2017 - 07:30
Coventry, UK, 12th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a nov
Tue, 02/05/2017 - 10:24
London, UK, 2nd May 2017 / Sciad Newswire / Roche Diagnostics UK and Ireland launches the next generation of INR patient self-monitoring meter for patients on war
Mon, 24/10/2016 - 09:00
NALIA Systems, a developer of novel multiplex immunodiagnostic systems for clinical and research applications, announces the expansion of its board following the recent successful £500,000 fund raising.
Tue, 18/10/2016 - 14:45
London, UK, 18th October 2016 / Sciad Newswire / NALIA Systems, a developer of novel multiplex immunodiagnostic systems for clinical and research applications, ha
ProAxsis
Fri, 30/09/2016 - 10:12
ProAxsis Limited is pleased to announce that it has successfully registered a CE Mark for its novel ProteaseTag® Active Neutrophil Elastase Immunoassay.
Thu, 05/05/2016 - 09:00
Mercia has committed follow-on capital to Medherant Ltd. Medherant’s patch, known as the TEPI-patch®, is a thin, strong, easy-to-apply and easy-to-remove patch capable of delivering higher doses of drugs.
Wed, 20/01/2016 - 13:00
BÜHLMANN Laboratories is proud to announce the availability of its products directly from its new North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire.

Pages